Compile Data Set for Download or QSAR
Report error Found 428 Enz. Inhib. hit(s) with all data for entry = 819
TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292711(US10106501, Example A)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292717(US10106501, Example A1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292718(US10106501, Example A1-11)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292719(US10106501, Example AP-6)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292720(US10106501, Example AQ-4 | US10106501, Example AQ-...)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292720(US10106501, Example AQ-4 | US10106501, Example AQ-...)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292722(US10106501, Example AQ-5)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292723(US10106501, Example B)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292724(US10106501, Example B-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292725(US10106501, Example B-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292729(US10106501, Example B-6)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292730(US10106501, Example B-7)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292731(US10106501, Example B-8)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292732(US10106501, Example B-9)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292740(US10106501, Example B-17)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292741(US10106501, Example B-18)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292742(US10106501, Example B-19)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292743(US10106501, Example B-20)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292744(US10106501, Example B-21)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292745(US10106501, Example B-22)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292746(US10106501, Example B-23)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292747(US10106501, Example B-24)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292748(US10106501, Example B-25)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292749(US10106501, Example B-26)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292750(US10106501, Example GH)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292755(US10106501, Example CZ-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292757(US10106501, Example D)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292758(US10106501, Example D-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292759(US10106501, Example D-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292761((2,4-dichloro-3-((3,7-dimethyl-5-(trifluoromethyl)...)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292762(US10106501, Example DH1-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292763(US10106501, Example DH1-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292764(US10106501, Example DJ1-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292765(US10106501, Example DJ1-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292766(US10106501, Example DJ1-3)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292767(US10106501, Example DP-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292768(US10106501, Example DP-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292769(US10106501, Example DP-3)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292770(US10106501, Example DU)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292771(US10106501, Example DU1-1)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292772(US10106501, Example DU1-2)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292773(US10106501, Example DV)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292774(US10106501, Example DW)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292775(US10106501, Example DX)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292776(US10106501, Example DY)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292777(US10106501, Example DZ)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292779(US10106501, Example EA)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292780(US10106501, Example EB)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292781(US10106501, Example EC)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

TargetNuclear receptor ROR-gamma(Human)
Abbvie

US Patent
LigandPNGBDBM292782(US10106501, Example ED)
Affinity DataIC50: 100nMAssay Description:The primary screen was performed by transient transactivation assays. These cell-based assays were carried out using Cos-7 cells transfected with a c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 428 total ) | Next | Last >>
Jump to: